Financials
- Market Capitalization 630.16 B
- Employee 141 K
- Founded N/A
- CEO Joaquin Duato
- Website www.jnj.com
- Headquarter New Jersey, United States
- FIGI BBG000BMHYD1
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
18.82
Relación precio/flujo de caja
5.35
Dividendos por acción
5.14
Rendimiento por dividendo, %
2.48
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 12 | LLY Eli Lilly and Company Common Stock | 1178.70 USD | +0.75% | +2.41% | +3.20% | +42.01% | 1.11 T USD | ||
| 24 | ABBV AbbVie Inc. Common Stock | 276.48 USD | +1.49% | +5.53% | +4.84% | +20.21% | 488.57 B USD | ||
| 35 | MRK Merck & Company, Inc. Common Stock | 145.57 USD | +2.23% | +1.58% | -0.84% | +69.96% | 359.15 B USD | ||
| 48 | NVS Novartis AG | 143.77 USD | +0.45% | +2.01% | +1.50% | +10.93% | 274.33 B USD |